CL2022002538A1 - Aplicación tópica repetida del parche de capsaicina para tratar pacientes - Google Patents

Aplicación tópica repetida del parche de capsaicina para tratar pacientes

Info

Publication number
CL2022002538A1
CL2022002538A1 CL2022002538A CL2022002538A CL2022002538A1 CL 2022002538 A1 CL2022002538 A1 CL 2022002538A1 CL 2022002538 A CL2022002538 A CL 2022002538A CL 2022002538 A CL2022002538 A CL 2022002538A CL 2022002538 A1 CL2022002538 A1 CL 2022002538A1
Authority
CL
Chile
Prior art keywords
capsaicinoid
capsaicin
high concentration
topical application
treat patients
Prior art date
Application number
CL2022002538A
Other languages
English (en)
Inventor
Eerdekens Marielle
Engelen Sylvia
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of CL2022002538A1 publication Critical patent/CL2022002538A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención hace referencia al tratamiento repetido de una afección neuropática, pre-ferentemente dolor neuropático periférico, mediante la aplicación de una o más unidades de dosis tópicas de capsaicinoide y/o capsaicinas de alta concentración, preferentemente par-ches de capsaicinoide y/o capsaicina de alta concentración, a pacientes que previamente no respondieron o respondieron de manera insuficiente a una aplicación previa de una o más unidades de dosis tópicas de capsaicinoide y/o capsaicinas de alta concentración, preferen-temente parches de capsaicinoide y/o capsaicina de alta concentración o cualquier otra for-mulación de capsaicinoide y/o capsaicina de alta concentración administrada previamente en forma tópica.
CL2022002538A 2020-03-17 2022-09-15 Aplicación tópica repetida del parche de capsaicina para tratar pacientes CL2022002538A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20163651 2020-03-17
EP20167982 2020-04-03
EP20173133 2020-05-06

Publications (1)

Publication Number Publication Date
CL2022002538A1 true CL2022002538A1 (es) 2023-04-21

Family

ID=74871416

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022002538A CL2022002538A1 (es) 2020-03-17 2022-09-15 Aplicación tópica repetida del parche de capsaicina para tratar pacientes

Country Status (11)

Country Link
US (1) US20230157977A1 (es)
EP (1) EP4121027A1 (es)
JP (1) JP2023517745A (es)
KR (1) KR20220154160A (es)
CN (1) CN115297853A (es)
AU (1) AU2021238637A1 (es)
BR (1) BR112022018608A2 (es)
CA (1) CA3175582A1 (es)
CL (1) CL2022002538A1 (es)
MX (1) MX2022011400A (es)
WO (1) WO2021185887A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023178413A1 (en) * 2022-03-21 2023-09-28 360Medlink Inc. A method and a system for monitoring a treatment area of a patient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
MXPA05006670A (es) 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
EP2907503A1 (en) 2003-04-10 2015-08-19 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
DK1613297T3 (da) 2003-04-14 2007-09-24 Lohmann Therapie Syst Lts Terapeutisk plaster med polysiloxanmatrix indeholdende capsaicin
US20060100272A1 (en) 2004-06-02 2006-05-11 Sri International Formulations for the treatment of pain
US7771760B2 (en) 2005-04-01 2010-08-10 Neurogesx, Inc. Oils of capsaicinoids and methods of making and using the same
CA2854206C (en) 2011-09-09 2018-04-10 Api Genesis, Llc Pain relief compositions, comprising a trpv1 selective agonist, and manufacture and uses thereof
JP6563954B2 (ja) 2014-04-15 2019-08-21 ヴィズリ・ヘルス・サイエンスィズ・エルエルシー 痛みの緩和のための局所組成物、製造および使用

Also Published As

Publication number Publication date
CA3175582A1 (en) 2021-09-23
US20230157977A1 (en) 2023-05-25
CN115297853A (zh) 2022-11-04
MX2022011400A (es) 2022-10-13
JP2023517745A (ja) 2023-04-26
AU2021238637A1 (en) 2022-11-10
EP4121027A1 (en) 2023-01-25
BR112022018608A2 (pt) 2022-11-08
KR20220154160A (ko) 2022-11-21
WO2021185887A1 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
Nassif et al. Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review
Khodaeiani et al. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris
Bercovitch Topical chemotherapy of actinic keratoses of the upper extremity with tretinoin and 5‐fluorouracil: a double‐blind controlled study
Kucera et al. Topical symphytum herb concentrate cream against myalgia: a randomized controlled double-blind clinical study
CL2022002538A1 (es) Aplicación tópica repetida del parche de capsaicina para tratar pacientes
CL2020002512A1 (es) Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de jak.
Cacchio et al. Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren®) in addition to complex decongestive therapy on management of breast cancer-related lymphedema
Mishra et al. Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study
Niazi et al. Effect of complementary medicine on pain relief and wound healing after cesarean section: A systematic review
Evans A comparison of terbinafine (Lamisil®) 1% cream given for one week with clotrimazole (Canesten®) 1% cream given for four weeks, in the treatment of tinea pedis
CN105999013B (zh) 一种沉香活络油及其制备方法
Padilla et al. Negative pressure wound therapy with instillation and dwell for the management of a complex burn: a case report and review of the literature
Xu et al. R esina D raconis as a topical treatment for pressure ulcers: A systematic review and meta‐analysis
Hassan et al. ROLE OF ORAL ZINC SULPHATE IN WARTS-A PLACEBO CONTROLLED, SINGLE-BLINDED STUDY.
CL2022002708A1 (es) Régimen para la aplicación tópica repetida del parche de capsaicina
BR112022010733A2 (pt) Métodos para tratar dor
Argoff Topical agents for the treatment of chronic pain
Robertson Managing pharyngeal and oral mucosal pain
Asih et al. A randomized controlled trial of combination of peppermint, lavender, and turmeric oil for antipruritic agent in pregnant women.
CN103349717A (zh) 一种治疗难愈合伤口、多种创伤及化脓性疾病的复方药物
Fadheel et al. Evaluation of isotretinoin gel and oral zinc sulphate in the treatment of plane warts
Barros et al. Adverse reactions and dietary supplements
Horaginamath et al. Effect of Talisadi Taila in the management of Sadhyo Vrana-A Case Study
Chowdhury et al. Oral azithromycin pulse therapy and daily topical adapalene in the treatment of acne vulgaris: an open randomized noncomparative study
Martinez-Abreu et al. Therapeutic effects of Ozone therapy in adult periodontitis treatment, subtypes I and II.